“Big Pharma’s longstanding pattern of utilizing the REMS process to forestall generic and biosimilar medications from reaching patients is an anticompetitive and cynical abuse of an important tool for patient safety.”
“The FAST Generics Act represents market-based reforms that will increase competition and ensure that lifesaving medications can safely reach patients at an affordable price.”
American Academy of Family Physicians Joins CSRxP The Campaign for Sustainable Rx Pricing (CSRxP) today announced that the American Academy of Family Physicians (AAFP) joined the Campaign. […]
“We must ‘bring down the artificially high price of drugs and bring them down immediately.’ That’s what the President said in his address to Congress – and the American people agree.